In situ hybridization studies, promoter analyses and antisense RNA exp
eriments have implicated transcription factor GATA-4 in the regulation
of cardiomyocyte differentiation. In this study, we utilized Gata4(-/
-) embryonic stem (ES) cells to determine whether this transcription f
actor is essential for cardiomyocyte lineage commitment, First, we ass
essed the ability of Gata4(-/-) ES cells form cardiomyocytes during in
vitro differentiation of embryoid bodies, Contracting cardiomyocytes
were seen in both wildtype and Gata4(-/-) embryoid bodies, although ca
rdiomyocytes were observed more often in wild type than in mutant embr
yoid bodies, Electron microscopy of cardiomyocytes in the Gata4(-/-) e
mbryoid bodies revealed the presence of sarcomeres and junctional comp
lexes, while immunofluorescence confirmed the presence of cardiac myos
in, To assess the capacity of Gata4(-/-) ES cells to differentiate int
o cardiomyocytes in vivo, we prepared and analyzed chimeric mice, Gata
4(-/-) ES cells were injected into 8-cell-stage embryos derived from R
OSA26 mice, a transgenic line that expresses beta-galactosidase in all
cell types, Chimeric embryos were stained with X-gal to discriminate
ES cell- and host-derived tissue, Gata4(-/-) ES cells contributed to e
ndocardium, myocardium and epicardium. In situ hybridization showed th
at myocardium derived from Gata4(-/-) ES cells expressed several cardi
ac-specific transcripts, including cardiac alpha-myosin heavy chain, t
roponin C, myosin light chain-2v, Nkx-2.5/Csx, dHAND, eHAND and GATA-6
, Taken together these results indicate that GATA-4 is not essential f
or terminal differentiation of cardiomyocytes and suggest that additio
nal GATA-binding proteins known to be in cardiac tissue, such as GATA-
5 or GATA-6, may compensate for a lack of GATA-4.